Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
84.34
1.58 (1.91%)
At close: Aug 15, 2025, 3:42 PM

Merck & Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.81B 15.53B 15.62B 16.66B 16.11B 15.78B 14.63B 15.96B 15.04B 14.49B 13.83B 14.96B 14.59B 15.9B 13.52B 13.15B 11.4B 10.63B
Cost of Revenue
3.56B 3.42B 3.83B 4.08B 3.75B 3.54B 3.91B 4.26B 4.02B 3.93B 3.88B 3.93B 4.22B 5.38B 3.87B 3.45B 3.1B 3.2B
Gross Profit
12.25B 12.11B 11.8B 12.58B 12.37B 12.23B 10.72B 11.7B 11.01B 10.56B 9.95B 11.03B 10.38B 10.52B 9.65B 9.7B 8.3B 7.43B
Operating Income
5.55B 5.94B 4.35B 3.98B 6.13B 5.76B -1.71B 5.87B -5.01B 3.81B 3.49B 4.11B 5.07B 5.62B 3.75B 4.92B 1.7B 2.83B
Interest Income
69M 109M 146M 127M 69M 73M 70M 73M 109M 112M 95M 40M 15M 7M 9M 7M 9M 11M
Pretax Income
5B 5.9B 4.17B 4.09B 6.01B 5.67B -2.05B 5.62B -5.33B 3.65B 3.51B 3.58B 4.49B 4.86B 3.91B 5.27B 1.72B 2.99B
Net Income
4.43B 5.08B 3.74B 3.16B 5.46B 4.76B -1.23B 4.75B -5.97B 2.82B 3.02B 3.25B 3.94B 4.31B 3.76B 4.57B 1.54B 3.18B
Selling & General & Admin
2.65B 2.55B 2.86B 2.73B 2.74B 2.48B 2.8B 2.52B 2.7B 2.48B 2.69B 2.52B 2.51B 2.32B 2.83B 2.34B 2.28B 2.19B
Research & Development
4.05B 3.62B 4.58B 5.86B 3.5B 3.99B 9.63B 3.31B 13.32B 4.28B 3.77B 4.4B 2.8B 2.58B 3.07B 2.44B 4.32B 2.41B
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
6.7B 6.17B 7.45B 8.59B 6.24B 6.47B 12.43B 5.83B 16.02B 6.75B 6.46B 6.92B 5.31B 4.9B 5.9B 4.78B 6.6B 4.6B
Interest Expense
305M 313M 328M 330M 310M 303M 310M 317M 277M 242M 235M 244M 240M 243M 209M 196M 202M 200M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.25B 9.59B 11.28B 12.67B 9.98B 10.02B 16.34B 10.09B 20.05B 10.68B 10.34B 10.85B 9.53B 10.28B 9.77B 8.23B 9.71B 7.8B
Income Tax Expense
571M 818M 426M 929M 545M 903M -820M 870M 637M 825M 495M 330M 538M 554M 85M 695M 503M 238M
Shares Outstanding (Basic)
2.51B 2.53B 2.54B 2.54B 2.53B 2.53B 2.55B 2.54B 2.54B 2.54B 2.54B 2.53B 2.53B 2.53B 2.53B 2.53B 2.53B 2.53B
Shares Outstanding (Diluted)
2.51B 2.53B 2.54B 2.54B 2.54B 2.54B 2.55B 2.55B 2.54B 2.55B 2.55B 2.54B 2.54B 2.54B 2.54B 2.54B 2.54B 2.54B
EPS (Basic)
1.76 2.01 1.47 1.24 2.15 1.88 -0.48 1.87 -2.35 1.11 1.19 1.28 1.56 1.70 1.49 1.81 0.61 1.26
EPS (Diluted)
1.76 2.01 1.49 1.24 2.14 1.87 -0.48 1.86 -2.35 1.11 1.18 1.28 1.55 1.70 1.48 1.80 0.61 1.25
EBITDA
6.42B 7.32B 5.7B 5.61B 7.45B 6.96B -772M 6.95B -4.16B 4.88B 4.64B 4.79B 5.67B 6.22B 4.95B 6.22B 2.65B 4.08B
EBIT
5.3B 6.22B 4.5B 4.42B 6.32B 5.97B -1.74B 5.94B -5.06B 3.89B 3.75B 3.83B 4.73B 5.1B 4.12B 5.46B 1.92B 3.19B
Depreciation & Amortization
1.12B 1.1B 1.2B 1.19B 1.13B 984M 964M 1.01B 903M 991M 892M 959M 938M 1.12B 835M 759M 728M 892M